K. Rajender Reddy

K. Rajender Reddy

University of Pennsylvania
在 uphs.upenn.edu 的电子邮件经过验证
被引用次数：86234
viral hepatitis cirrhosis liver cancer liver transplantation
Jaime Bosch (or Jaume Bosch)

Jaime Bosch (or Jaume Bosch)

Professor of Medicine. University of Barcerlona-IDIBAPS, and Guest Professor, Bern …
在 clinic.ub.es 的电子邮件经过验证
被引用次数：84284
Portal hypertension Cirrhosis Splanchnic circulation endothelial biology
Rohit Loomba, MD, MHSc

Rohit Loomba, MD, MHSc

University of California at San Diego
在 ucsd.edu 的电子邮件经过验证
被引用次数：59099
NAFLD NASH cirrhosis liver disease outcomes
Richard Moreau

Richard Moreau

Inserm
在 inserm.fr 的电子邮件经过验证
被引用次数：42207
Cirrhosis ACLF Inflammation
Juan G Abraldes

Juan G Abraldes

Professor. Division of Gastroenterology (Liver Unit). University of Alberta Hospital. Edmonton …
在 ualberta.ca 的电子邮件经过验证
被引用次数：30999
Cirrhosis portal hypertension liver
Emmanuel Tsochatzis

Emmanuel Tsochatzis

Sheila Sherlock Liver Unit and UCL Institute of Liver and Digestive Health
在 ucl.ac.uk 的电子邮件经过验证
被引用次数：26067
Cirrhosis NAFLD non-invasive fibrosis markers HCC metabolic liver disease
Ahmad R. Dehpour

Ahmad R. Dehpour

Distinguished Professor of Pharmacology, Tehran University of Medical Sciences
在 sina.tums.ac.ir 的电子邮件经过验证
被引用次数：20107
Nitric Oxide Opioids Seizures Cholestasis Cirrhosis
Amedeo Lonardo

Amedeo Lonardo

Azienda ospedaliero universitaria modena
在 ausl.mo.it 的电子邮件经过验证
被引用次数：18424
Fatty liver NASH cirrhosis metabolic syndrome
Aleksander Krag

Aleksander Krag

Professor of Hepatology, Odense Universityhospital
在 rsyd.dk 的电子邮件经过验证
被引用次数：18187
Liver diseases Cirrhosis Fibrosis Biomarkers
Rui Tato Marinho

Rui Tato Marinho

University Hospital of Santa Maria, Medical School of Lisbon, Portugal
在 sapo.pt 的电子邮件经过验证
被引用次数：11511
Gastroenterology Hepatology Hepatitis C Hepatocellular Carcinoma cirrhosis
1 - 10